MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/mpa.0000000000002448

Медицинская библиотека · Pancreas · 2025

Preoperative Anemia as a Prognostic Risk Factor for Inferior Oncological Survival Following Resection for Pancreatic Ductal Adenocarcinoma.

Bos Mylena D, Meyer N Helge, Wijma Allard G, Khatib-Chahidi Karl, van den Broek Evert, Ho Cassandra S L, Meerdink Mark, Klaase Joost M, Bockhorn Maximilian, Hoogwater Frederik J H, Nijkamp Maarten W

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

OBJECTIVES

A significant proportion of patients undergoing surgery for pancreatic ductal adenocarcinoma (PDAC) are anemic at the time of resection. In these patients, blood transfusions are omitted because of their potential negative impact on oncological outcomes. The present study aimed to determine the prognostic value of preoperative anemia in resected PDAC patients, irrespective of blood transfusion status.

MATERIALS AND

METHODS

This retrospective 2-center cohort study included patients who underwent resection for PDAC between 2013 and 2022. The prognostic role of preoperative anemia was investigated using Cox proportional-hazard regression analysis. A subgroup analysis excluded PDAC patients who received a perioperative blood transfusion.

RESULTS

Among 280 included PDAC patients, 110 (39%) were found to have preoperative anemia. Preoperative anemia was associated with increased use of blood transfusions, with 44 patients (16%) requiring transfusion perioperatively. In the whole cohort, preoperative anemia was an independent predictor of lower disease-free survival (hazard ratio [HR] = 1.518; 95% confidence interval [CI] = 1.103-2.090, P  = 0.011), but not overall survival. However, when patients who received a perioperative blood transfusion were excluded, preoperative anemia was independently associated with both lower disease-free survival (HR = 1.636; 95% CI = 1.113-2.404, P  = 0.012) and overall survival (HR = 1.484; 95% CI = 1.036-2.127, P  = 0.031).

CONCLUSIONS

Preoperative anemia was identified as an independent risk factor for inferior oncological survival after resection for PDAC. These results support the need for increased awareness regarding the potential adverse effects of preoperative anemia on oncological outcomes in PDAC.

Для цитирования: Bos Mylena D, Meyer N Helge, Wijma Allard G, Khatib-Chahidi Karl, van den Broek Evert, Ho Cassandra S L, Meerdink Mark, Klaase Joost M, Bockhorn Maximilian, Hoogwater Frederik J H, Nijkamp Maarten W. Preoperative Anemia as a Prognostic Risk Factor for Inferior Oncological Survival Following Resection for Pancreatic Ductal Adenocarcinoma.. Pancreas. 2025. DOI: 10.1097/mpa.0000000000002448.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.